# Immunogenicity of SA 14-14-2 JE Vaccine

> **NCT01635816** · PHASE4 · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 1000 (actual)

## Conditions studied

- Healthy Infants

## Interventions

- **BIOLOGICAL:** JE Vaccine existing facility
- **BIOLOGICAL:** JE vaccine new plant lot 1
- **BIOLOGICAL:** JE vaccine new plant lot 2
- **BIOLOGICAL:** JE vaccine new plant lot 3

## Key facts

- **NCT ID:** NCT01635816
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2016-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635816, "Immunogenicity of SA 14-14-2 JE Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01635816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*